In 2025, the UK peptide market continues to evolve, with growing interest from researchers exploring compounds that promote repair, regeneration, and metabolic balance. While peptides like BPC-157, TB-500, CJC-1295, and Ipamorelin are gaining popularity for their potential roles in tissue healing, hormone modulation, and anti-inflammatory research, it’s important to note that these substances are only legal for research use. They cannot be marketed or sold for human consumption unless licensed by the Medicines and Healthcare products Regulatory Agency (MHRA). When purchased under proper “for research use only” labelling, these peptides remain within legal boundaries for academic and laboratory investigations.